Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Biosimilars Deals 2023
Biosimilars Deals 2024
Chris Vindurampulle
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Paul Johns
Trade Marks

Evotec Biologics Chosen by U.S. Department of Defense for Manufacturing Optimisation Program

Jun 25, 2024

On 25 June 2024, Evotec announced that its subsidiary, Just – Evotec Biologics, Inc., has been selected by the U.S. Department of Defense to develop an accelerated monoclonal antibody development and manufacturing solution as part of the department’s Manufacturing Optimization Program. The multi-year program award, valued at up to USD$39 million, aims to bolster the U.S. Government’s rapid response capability with biologics medical countermeasures. 

Just-Evotec partnered with Sandoz in May of 2023 to develop and manufacture multiple biosimilar medicines (with an option for expansion).